Hence, in the past when ZES patients were treated with the conventional doses of H2R antagonists which were widely used in non-ZES patients, they continued to have symptoms, raising the possible awareness that they may have ZES. The gene discussed is HRH2; the disease is Zollinger-Ellison syndrome.